Cann Group Ltd has released a press release.
FY25 Results
Filed with ASX ·
On 6ix: 6ix.com/news/fy25-results-7
6ix hasn’t read this filing yet.
Earlier from Cann
- Preliminary Final Report
- Cann Group Receives $315k Funding Advance on R&D Refund
- Cann Settles Legal Dispute with Rua Biosciences
- CEO EGM Presentation
- Cann Group Receives $836k Funding Advance on R&D Refund
Later from Cann
- Interest and Facility Fees Update
- September 2025 Market Update
- Debt Facility Extension
- Trading Halt
- Major Debt Restructure and Capital Raise
Follow Cann into a list and get an email when it puts out news.
Follow Cann